Physician profile
Thomas A Coury
NPI 1386802072
$29,021.34
in general payments reported to CMS, 2019-2025
49 companies · $3,534 in 2025
The $3,534 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,256 · 2020: $5,751 · 2021: $4,240 · 2022: $5,600 · 2023: $2,490 · 2024: $3,151 · 2025: $3,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,360 · Travel and Lodging: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,360.11 |
| Travel and Lodging | $814.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $8,447.00 | 2019-2020 | |
| Abbott Laboratories | $8,241.66 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $5,291.59 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $1,516.97 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbvie INC. | $733.91 | 2021-2025 | Botox, Qulipta |
| Genesys Orthopedics Systems, L.L.C. | $638.98 | 2021 | |
| Collegium Pharmaceutical, INC. | $392.69 | 2020-2025 | Xtampza, Belbuca |
| Allergan, INC. | $363.80 | 2021-2022 | |
| Curonix LLC | $268.54 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biotronik Nro, INC. | $253.33 | 2024-2025 | Prospera |
| Nalu Medical, INC. | $248.74 | 2021-2024 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $230.09 | 2020-2024 | Mild Device Kit |
| Amgen INC. | $203.95 | 2019-2024 | Evenity, Prolia |
| Saol Therapeutics INC. | $198.28 | 2020-2021 | |
| Spr Therapeutics, INC | $178.86 | 2023 | Sprint Pns System |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Coury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.